Início › Câncer retal › Nova York

Ensaios clínicos de Câncer retal em Nova York

22 estudos para Câncer retal estão buscando participantes em locais em Nova York.

Cidades em Nova York

Texto oficial do estudo (Inglês)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Montefiore Medical Center-Einstein Campus, The Bronx
James J Peters VA Medical Center, The Bronx

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07283939

Family Communications After Genetic Testing

Glens Falls Hospital, Glens Falls

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Ellis Hospital ( Site 0098), Schenectady

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06997497

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07227636

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

NYU Langone Health Perlmutter Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07629960

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
Memorial Sloan Kettering Cancer Center, New York
e mais 1

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04165772

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Recrutando

Idades de 45 a 70 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05080673

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

University of Rochester Medical Center, Rochester

RecrutandoFase 2

Idades de 18 a 100 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Weill Cornell Medical College, New York
Brooklyn Methodist Hospital - NewYork Presbyterian, New York
New York Presbyterian Hospital - Queens, New York

RecrutandoFase 2

Idades de 18 a 90 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
e mais 4

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT06205485

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
Weill Cornell Medical College, New York
New York Presbyterian Hospital - Queens, New York

Recrutando

Idades de 18 a 90 · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NYU Langone Medical Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 12 de mai. de 2026 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Memorial Sloan Kettering Cancer Center, New York

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Columbia University Irving Medical Center, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
e mais 2

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NYU Langone Health, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2025 · NCT06682793

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Bassett Healthcare Network, Cooperstown

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 7 de mar. de 2023 · NCT04245683

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.